Tom H. Johnston

Increased 5‐HT_2A receptors in the temporal cortex of parkinsonian patients with visual hallucinations

Philippe Huot, Tom H. Johnston, Tayyeba Darr et al. · Movement Disorders · 2010 · 151 citations

Neuropsychology, Well-formed Visual Hallucinations, Psychopharmacology +18

Expression of human A53T alpha-synuclein in the rat substantia nigra using a novel AAV1/2 vector produces a rapidly evolving pathology with protein aggregation, dystrophic neurite architecture and nigrostriatal degeneration with potential to model the pathology of Parkinson's disease

James B. Koprich, Tom H. Johnston, M. Gabriela Reyes et al. · Molecular Neurodegeneration · 2010 · 144 citations · Full text

Reduction of l-DOPA-Induced Dyskinesia by the Selective Metabotropic Glutamate Receptor 5 Antagonist 3-[(2-Methyl-1,3-thiazol-4-yl)ethynyl]pyridine in the 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-Lesioned Macaque Model of Parkinson's Disease

Tom H. Johnston, Susan H. Fox, Matthew J. McIldowie et al. · Journal of Pharmacology and Experimental Therapeutics · 2010 · 137 citations

Progressive Neurodegeneration or Endogenous Compensation in an Animal Model of Parkinson's Disease Produced by Decreasing Doses of Alpha-Synuclein

James B. Koprich, Tom H. Johnston, Philippe Huot et al. · PLoS ONE · 2011 · 107 citations · Full text

Pharmacological characterization of psychosis‐like behavior in the MPTP‐lesioned nonhuman primate model of Parkinson's disease

Naomi P. Visanji, Jordi Gómez-Ramírez, Tom H. Johnston et al. · Movement Disorders · 2006 · 93 citations